ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017
Trading in the financial instruments of ASIT biotech, ISIN BE0974289218, on Euronext Brussels is suspended on the request of the company from 17/12/2018 at 15:00 CET until the publication of a press release.